Constructive Bio appoints biopharma leader Jim Weissman to its Board of Directors
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
Cambridge iGEM 2025 Team Visits Constructive Bio’s Recodery for Synthetic Biology Discussion
Constructive Bio hosted the Cambridge iGEM 2025 team at The Recodery for a technical discussion on synthetic biology research, as…
Constructive Bio Sponsors 2025 LMB–Institut Pasteur Symposium on Molecular Biology Research
Constructive Bio sponsored the 2025 LMB–Institut Pasteur Symposium at the MRC Laboratory of Molecular Biology in Cambridge, bringing together international…
Constructive Bio Founder and Chief Scientific Officer, Professor Jason Chin, named the 2026 Heinrich Wieland Prize recipient
Constructive Bio founder and CSO Professor Jason Chin received the SynBioBeta 2025 Impact Award, recognising his contributions to synthetic biology…
Constructive Bio CEO Ola Wlodek Presents on Genetic Code Expansion at Milner Therapeutics Institute
Constructive Bio CEO Ola Wlodek presented at the Milner Therapeutics Institute seminar series on rewriting genetic codes to expand the…
Professor Jason Chin Reappointed to UK Department for Science, Innovation and Technology Board
Constructive Bio’s founder and CSO, Professor Jason Chin, was reappointed as a Non-Executive Director on the UK Department for Science,…
